The aim of the present study was to investigate the effects of 5-aminosalicyclic acid (5-ASA) on the cell injury mediated by activated neutrophils. We used a system constituted of neutrophils, triggered with phorbol myristate acetate, and "Cr-labelied Daudi celis as targets. The results show that 5-ASA is capable of efficiently preventing neutrophilmediated lysis. 5-ASA was up to 10-fold more effective than taurine, which acts as an hypochlorous acid scavenger. Moreover, 5-ASA was found to compete with taurine for the neutrophil derived hypochlorous acid. The results are consistent with the conclusion that 5-ASA is capable of limiting the neutrophil mediated cell damage by scavenging the generated hypochlorous acid. This may represent a potential mechanism for the therapeutic action of 5-ASA in ulcerative colitis.
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The therapeutic benefit of 5-aminosalicylic acid (5-ASA) in ulcerative colitis is well established.' 2 It appears to act directly on the inflamed mucosa possibly by blocking cyclooxygenase and lipooxygenase metabolite mediated inflammation2' and/or by reducing the local generation of highly reactive oxygen species.4" This latter possibility is particularly attractive because of the neutrophil infiltration of the colonic mucosa, coupled with the well known ability of neutrophils to produce reactive oxygen species.6 Nevertheless, to our knowledge, the actual capacity of 5-ASA to interfere with the oxidative cell damage mediated by neutrophils has not been directly proved. In the present paper, using a cytotoxicity model generally accepted to study the neutrophil mediated cellular damage (phorbol myristate acetate -triggered neutrophils plus Daudi target cells),7 6 we provide evidence that 5-ASA is highly effective in limiting the neutrophil cytolytic potential. TauNH2, (TauNH2+hypochlorous acid-* TauNHCl+H20) was determined in the cell free supernatants by measuring spectrophotometrically (OD=412 nm, E=1 36x 104 mol/l/cm) the TauNHCI mediated oxidation of 5-thio-2-nitrobenzoic acid.'2 A series of experiments was also planned to detect the ability of 5-ASA to limit the formation of Tau NHC1 from reagent hypochlorous acid and TauNH2. These experiments were carried out by adding reagent hypochlorous acid (40 [tmol/l) to a mixture of TauNH2 (20 mmol/l) and 5-ASA in doses ranging from 0 05 to [-0 mmol/l (final volume of the reaction= 1 ml). After incubation for 10 minutes at 37°C, the amount of the generated TauNHCl was measured as described above.
OXYGEN CONSUMPTION ASSAY
The oxygen consumption by neutrophils was measured polarographically using a Clark electrode (Oxygen Monitor, Yellow Springs Instrument Co, Yellow Spring, Ohio) and using the technique described by Metcalf and coworkers.'3 Cell suspensions of 8x 106 neutrophils in 2 ml HBSS were agitated continuously at 37°C. Oxygen consumption was measured after stimulation with phorbol myristate acetate (10 ng/ml) and the results expressed as nanomoles of oxygen consumed by 4x 106 neutrophils per minute.
MYELOPEROXIDASE ASSAY
The myeloperoxidase activity released by neutrophils (106 cells/ml), incubated (one hour, 37°C) with 10 ng/ml phorbol myristate acetate, was determined in cell free supernatants as previously described. '°Briefly, the myeloperoxidase assay was done by using 0-167 mg/ml 0-dianisidine (Sigma) and 0-1 mmol/l H202 in 50 mmol/l phosphate buffer (pH=6). One unit of enzyme activity was defined as that oxidising 1 [tmol 0-dianisidine/min/25°C (od= 550, e= II 1 3 mmol/l/cm).
After incuba-Results nerated by the As shown in Figure 1 (Fig 3) . Thus, it appears that 5-ASA inhibits the neutrophil cytolysis primarily by trapping the generated hypochlorous acid.
The compound 5-ASA gave only slight inhibition of the neutrophil oxygen uptake and myeloperoxidase positive primary granule exocytosis. When used at the concentration of 1 mmol/l, 5-ASA inhibited the neutrophil oxygen consumption by 15-8%. Concentrations of 5-ASA lower than 1 mmol/l were completely ineffective (oxygen consumption by phorbol myristate acetate triggered neutrophils in the absence of the drug: 8-74 (0 70) nmol oxygen per 4x106 cells per minute, x(ISD), n=3). Finally, a slight inhibition (18-6%) of the myeloperoxidase release from neutrophils was only observed using relatively high doses (1 mmol/l) of 5-ASA (myeloperoxidase release from phorbol myristate acetate triggered neutrophils in the absence of the drug: 2-86 (0-32) mU/106 cells/lh, x(lSD) n=3).
Discussion
Our results suggest that 5-ASA is capable of inhibiting the neutrophil cytolytic efficiency by scavenging the generated hypochlorous acid (HOCI). In agreement with reports from other authors,7 '4 the generation of hypochlorous acid by the neutrophil myeloperoxidase pathway (H202+Cl MPO HOCl+H20) is crucial in promoting the neutrophil-dependent cell damage. In fact, TauNH2, capable of efficiently trapping the generated hypochlorous acid to yield TauNHCl,'2 inhibited the lysis. When compared on a molar basis, 5-ASA was much as 10-fold more effective than TauNH2 in reducing the neutrophil lytic activity. Also, 5-ASA was found to efficiently compete with TauNH2 for reagent or neutrophil derived hypochlorous acid, lowering the production of TauNHCl. Thus, it appears that the reaction between 5-ASA and hypochlorous acid is efficient enough to protect the target cells from the neutrophil delivered hypochlorous acid dependent attack. Consistent with such a conclusion, 5-ASA was found to reduce the lysis of fibroblasts by a neutrophil free myeloperoxidase-H202-Cl-system,"5 presumably able to produce hypochlorous acid. '14 The ability of 5-ASA reported here to limit the neutrophillytic efficiency observed at 5-ASA doses well within those detectable in the distal part of the intestinal lumen,'6 raises the possibility that this effect of the drug may contribute to its therapeutic activity in ulcerative colitis. This does not contradict the view that 5-ASA may also act by suppressing the production of prostaglandins or leucotrienes or both, Ih although the interference with the arachidonic acid metabolism has been reported to occur at doses of 5-ASA clearly higher than those used in the present set.
Moreover, owing to the wide range of biologic activities exerted by hypochlorous acid,'4 the cytoprotection against neutrophil attack is likely to be only one of the consequence of the hypochlorous acid-5-ASA interaction. In fact, the hypochlorous acid capacity of activating the neutrophil latent collagenase and inactivating proteinase inhibitors'4 suggests that the ability of 5-ASA to scavenge neutrophil derived hypochlorous acid may limit the degraradion of connective tissue components other than the tissue cell damage. Consistent with this view, 5- 
